USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like CAMI Research releases 64-pin Header Isolator for its CableEye cable and wire harness test systems February 9, 2018 Fiat Chrysler Announces Plan to Invest $1 Billion in Michigan Plant January 13, 2018 Universal mCloud announces acquisition of Fulcrum Automation Technologies July 12, 2019
CAMI Research releases 64-pin Header Isolator for its CableEye cable and wire harness test systems February 9, 2018